ClinConnect ClinConnect Logo
Search / Trial NCT06805422

Health-Related Physical Fitness Level from Smartwatches

Launched by KANSAS STATE UNIVERSITY · Jan 30, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how well smartwatches can help measure and track health-related physical fitness (HRPF), which includes exercise capacity, flexibility, strength, and endurance. The goal is to find a way to easily monitor fitness levels since being fit is important for staying active and reducing the risk of chronic diseases. The study is currently recruiting participants aged 20 to 60 who fall into different groups based on their training habits: those who regularly do aerobic exercise, those who focus on strength training, and those who have high flexibility.

To join the trial, participants should have been actively training or competing for at least the past two years, and they should meet specific activity levels based on their group. However, people with certain medical conditions, such as heart disease or severe lung issues, cannot participate. Those who take part in the study can expect to use smartwatches to track their fitness levels, which may help make fitness assessments easier and more accessible for everyone.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Group 1 (Aerobically Trained)
  • 20-60 years old
  • actively training or competing over the past 2 years
  • 3 or more days of vigorous activity accumulating approximately least 1500 MET min/week or 7 days of any combination of walking, moderate, or vigorous intense activities achieving a minimum of 3000 MET min/week
  • Group 2 (Strength trained)
  • 20-60 years old
  • actively training or competing over the past 2 years
  • 3 or more days of muscle-strengthening exercise at an intensity of approximately 5 out of 10
  • Group 3 (Not actively training)
  • 20-60 years old
  • actively training or competing over the past 2 years
  • 3 or more days of muscle-strengthening exercise at an intensity of approximately 5 out of 10
  • Group 5 (High flexibility)
  • 20-60 years old
  • Sit-and-reach performance is categorized as "very good" or excellent based on the American College of Sports Medicine's sit-and-reach evaluation criteria (Table 4.16 of ACSM's Guidelines for Exercise Testing and Prescription 9th edition).
  • Exclusion Criteria:
  • Exclusion criteria are the same for all groups.
  • History of cardiovascular disease (Cardiac, peripheral vascular, or cerebrovascular disease)
  • History of stable or unstable angina
  • History of cardiac dysrhythmias causing symptoms or hemodynamic consequences
  • History of hypertrophic cardiomyopathy
  • History of cardiac valvular disease (e.g., aortic stenosis)
  • History of pulmonary disease (Chronic obstructive pulmonary disease, asthma, interstitial lung disease, or cystic fibrosis)
  • History of pulmonary embolus
  • History of suspected or known aneurysm
  • History of metabolic disease (Diabetes mellitus (type I or II), thyroid disorders, renal or liver disease
  • History of renal disease
  • History of neuromotor, musculoskeletal, or rheumatoid disorders that are exacerbated by exercise
  • Current acute systemic infection, accompanied by fever and body aches.
  • Pain or discomfort in the chest, neck, jaw, arms, or other areas that may be due to myocardial ischemia (lack of adequate circulation)
  • Shortness of breath at rest, during daily activities, or with mild exertion
  • Dizziness or syncope (fainting)
  • Orthopnea (breathing discomfort when not in an upright position) or paroxysmal nocturnal dyspnea (interrupted breathing at night)
  • Ankle edema (swelling)
  • Palpitations (abnormal rapid beating of the heart) or tachycardia (rapid heartbeat)
  • Intermittent claudication (cramping pain and weakness in legs, especially calves, during walking due to inadequate blood supply to muscles)
  • Known heart murmur (atypical heart sound indicating a structural or functional abnormality)
  • Unusual or unexplained fatigue
  • Severe arterial hypertension (i.e., systolic blood pressure of \>200 mm Hg and/or a diastolic blood pressure of \>110 mm Hg) at rest.

About Kansas State University

Kansas State University (KSU) is a leading research institution dedicated to advancing knowledge and improving health outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, KSU leverages its diverse expertise in veterinary and human medicine, agricultural sciences, and public health to conduct rigorous clinical research. The university is committed to ethical standards, participant safety, and the dissemination of impactful findings that contribute to the scientific community and society at large. Through its clinical trials, KSU aims to address pressing health challenges and foster the development of new therapeutic strategies.

Locations

Manhattan, Kansas, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported